Literature DB >> 28137903

Subcorneal pustular dermatosis and episcleritis associated with poorly controlled ulcerative colitis.

Jeffrey J Wargo1, Megan Adams2, Julian Trevino3.   

Abstract

A man aged 56 years with a history of ulcerative colitis (UC) status postsubtotal colectomy was hospitalised with fevers, dry cough, eye redness and a new bloody, mucoid rectal discharge. 2 months prior to admission, the dermatologist had started him on dapsone for subcorneal pustular dermatosis but did not recognise that he had recently self-discontinued mesalamine enemas, inducing a flare of his UC. After a thorough inpatient evaluation, including flexible sigmoidoscopy, active UC involving the rectal stump was determined to be driving his dermatological and ophthalmological findings. By reinstituting mesalamine enemas, control of his UC was achieved and the extraintestinal manifestations of his inflammatory bowel disease (IBD) resolved. This case illustrates the importance of careful history taking and of early recognition of extraintestinal manifestations of IBD in order to appropriately target treatment and prevent unnecessary morbidity. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28137903      PMCID: PMC5293954          DOI: 10.1136/bcr-2016-218123

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  An unusual severe case of subcorneal pustular dermatosis treated with cyclosporine and prednisolone.

Authors:  C O Zachariae; K Rossen; K Weismann
Journal:  Acta Derm Venereol       Date:  2000 Sep-Oct       Impact factor: 4.437

2.  Successful treatment of long-standing, recalcitrant subcorneal pustular dermatosis with etanercept.

Authors:  Monica K Bedi
Journal:  Skinmed       Date:  2007 Sep-Oct

3.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

4.  Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).

Authors:  C Voigtländer; M Lüftl; G Schuler; M Hertl
Journal:  Arch Dermatol       Date:  2001-12

Review 5.  Successful treatment of subcorneal pustular dermatosis (Sneddon-wilkinson disease) by acitretin: report of a case.

Authors:  V Marlière; M Beylot-Barry; C Beylot; M Doutre
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

6.  Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.

Authors:  Elena Ricart; Remo Panaccione; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325

7.  Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.

Authors:  Maxwell B Sauder; Steven J Glassman
Journal:  Int J Dermatol       Date:  2013-03-14       Impact factor: 2.736

Review 8.  Subcorneal pustular dermatosis: 50 years on.

Authors:  S Cheng; E Edmonds; M Ben-Gashir; R C Yu
Journal:  Clin Exp Dermatol       Date:  2008-03-18       Impact factor: 3.470

Review 9.  Sneddon-Wilkinson disease treated with etanercept: report of two cases.

Authors:  D R Berk; M A Hurt; C Mann; D Sheinbein
Journal:  Clin Exp Dermatol       Date:  2008-08-09       Impact factor: 3.470

10.  Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.

Authors:  David Farhi; Jacques Cosnes; Nada Zizi; Olivier Chosidow; Philippe Seksik; Laurent Beaugerie; Selim Aractingi; Kiarash Khosrotehrani
Journal:  Medicine (Baltimore)       Date:  2008-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.